Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Tongluo Formula
- Development stage
- Preclinical
- Lead developer
- Shanghai Municipal Hospital of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Jianpi Tongluo Formula is a Traditional Chinese Medicine (TCM) herbal decoction developed by the Shanghai Traditional Chinese Medicine Hospital. It is primarily investigated for the treatment of patients with stage III colorectal cancer following surgical resection. The formula is designed based on TCM principles of strengthening the spleen (Jianpi) and unblocking the collaterals (Tongluo) to improve clinical outcomes and safety in postoperative recovery. Research into its efficacy includes the analysis of the gut microbiome and metabolomic profiles to understand its systemic impact on cancer patients and its potential to modulate the internal environment to prevent recurrence.
- Other names
- Jianpi Tongluo Fang
Beyond the preview
Go deeper on Jianpi Tongluo Formula.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jianpi Tongluo Formula.